1. Home
  2. ASND vs BEN Comparison

ASND vs BEN Comparison

Compare ASND & BEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

N/A

Current Price

$233.32

Market Cap

13.2B

Sector

Health Care

ML Signal

N/A

Logo Franklin Resources Inc.

BEN

Franklin Resources Inc.

N/A

Current Price

$25.58

Market Cap

12.6B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ASND
BEN
Founded
2006
1947
Country
Denmark
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
12.6B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ASND
BEN
Price
$233.32
$25.58
Analyst Decision
Strong Buy
Hold
Analyst Count
16
11
Target Price
$264.13
$24.64
AVG Volume (30 Days)
638.0K
4.0M
Earning Date
02-11-2026
01-30-2026
Dividend Yield
N/A
5.17%
EPS Growth
N/A
7.28
EPS
N/A
0.91
Revenue
$758,592,045.00
$8,770,700,000.00
Revenue This Year
$99.54
N/A
Revenue Next Year
$84.40
$5.65
P/E Ratio
N/A
$28.08
Revenue Growth
97.46
3.45
52 Week Low
$118.03
$16.25
52 Week High
$238.84
$26.25

Technical Indicators

Market Signals
Indicator
ASND
BEN
Relative Strength Index (RSI) 64.45 59.78
Support Level $200.69 $25.32
Resistance Level $238.84 $25.84
Average True Range (ATR) 11.62 0.52
MACD 2.42 -0.05
Stochastic Oscillator 88.16 67.73

Price Performance

Historical Comparison
ASND
BEN

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

About BEN Franklin Resources Inc.

Franklin Resources provides investment services for individual and institutional investors. At the end of July 2025, Franklin had $1.617 trillion in managed assets, composed primarily of equity (41%), fixed-income (27%), multi-asset/balanced (11%) funds, alternatives (16%) and money market funds (5%). Distribution tends to be weighted between retail investors (56% of AUM) and institutional accounts (41%), with high-net-worth clients accounting for the remainder. Franklin is one of the more global of the US-based asset managers we cover, with 31% of its assets under management invested in global/international strategies and just as much sourced from clients domiciled outside the United States.

Share on Social Networks: